company background image
RDNT

RadNet NasdaqGM:RDNT Stock Report

Last Price

US$17.73

Market Cap

US$996.8m

7D

-1.3%

1Y

-48.4%

Updated

04 Jul, 2022

Data

Company Financials +
RDNT fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance4/6
Financial Health2/6
Dividends0/6

RDNT Stock Overview

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States.

RadNet Competitors

Price History & Performance

Summary of all time highs, changes and price drops for RadNet
Historical stock prices
Current Share PriceUS$17.73
52 Week HighUS$38.84
52 Week LowUS$16.44
Beta1.71
1 Month Change-10.95%
3 Month Change-17.84%
1 Year Change-48.44%
3 Year Change27.74%
5 Year Change130.26%
Change since IPO1,673.00%

Recent News & Updates

Jul 01
RadNet (NASDAQ:RDNT) Is Reinvesting At Lower Rates Of Return

RadNet (NASDAQ:RDNT) Is Reinvesting At Lower Rates Of Return

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

Jun 17
Is It Time To Consider Buying RadNet, Inc. (NASDAQ:RDNT)?

Is It Time To Consider Buying RadNet, Inc. (NASDAQ:RDNT)?

RadNet, Inc. ( NASDAQ:RDNT ), is not the largest company out there, but it received a lot of attention from a...

May 11
Is RadNet (NASDAQ:RDNT) A Risky Investment?

Is RadNet (NASDAQ:RDNT) A Risky Investment?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Shareholder Returns

RDNTUS HealthcareUS Market
7D-1.3%0.8%-2.2%
1Y-48.4%4.4%-19.1%

Return vs Industry: RDNT underperformed the US Healthcare industry which returned 4.4% over the past year.

Return vs Market: RDNT underperformed the US Market which returned -21.2% over the past year.

Price Volatility

Is RDNT's price volatile compared to industry and market?
RDNT volatility
RDNT Average Weekly Movement6.1%
Healthcare Industry Average Movement9.5%
Market Average Movement8.1%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.3%

Stable Share Price: RDNT is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: RDNT's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19817,020Howard Bergerhttps://www.radnet.com

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems for the diagnostic imaging industry, including picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of images in the field of mammography, as well as AI solutions for lung and prostate cancer.

RadNet Fundamentals Summary

How do RadNet's earnings and revenue compare to its market cap?
RDNT fundamental statistics
Market CapUS$996.77m
Earnings (TTM)US$18.28m
Revenue (TTM)US$1.34b

54.5x

P/E Ratio

0.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
RDNT income statement (TTM)
RevenueUS$1.34b
Cost of RevenueUS$1.03b
Gross ProfitUS$310.31m
Other ExpensesUS$292.03m
EarningsUS$18.28m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.33
Gross Margin23.08%
Net Profit Margin1.36%
Debt/Equity Ratio178.4%

How did RDNT perform over the long term?

See historical performance and comparison
We’ve recently updated our valuation analysis.

Valuation

Is RDNT undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • PEG Ratio

Key Valuation Metric

Which metric is best to use when looking at relative valuation for RDNT?

Other financial metrics that can be useful for relative valuation.

RDNT key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue1.8x
Enterprise Value/EBITDA13x
PEG Ratio3.2x

Price to Earnings Ratio vs Peers

How does RDNT's PE Ratio compare to its peers?

RDNT PE Ratio vs Peers
The above table shows the PE ratio for RDNT vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average31.2x
NRC National Research
26.6xn/aUS$978.6m
ADUS Addus HomeCare
30.1x15.7%US$1.3b
DCGO DocGo
20.2x24.2%US$729.9m
INNV InnovAge Holding
47.6x84.0%US$603.1m
RDNT RadNet
54.5x17.0%US$996.8m

Price-To-Earnings vs Peers: RDNT is expensive based on its Price-To-Earnings Ratio (54.5x) compared to the peer average (31.2x).


Price to Earnings Ratio vs Industry

How does RDNT's PE Ratio compare vs other companies in the US Healthcare Industry?

Price-To-Earnings vs Industry: RDNT is expensive based on its Price-To-Earnings Ratio (54.5x) compared to the US Healthcare industry average (18.8x)


Price to Earnings Ratio vs Fair Ratio

What is RDNT's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

RDNT PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio54.5x
Fair PE Ratio28x

Price-To-Earnings vs Fair Ratio: RDNT is expensive based on its Price-To-Earnings Ratio (54.5x) compared to the estimated Fair Price-To-Earnings Ratio (28x).


Share Price vs Fair Value

What is the Fair Price of RDNT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: RDNT ($17.73) is trading above our estimate of fair value ($8.61)

Significantly Below Fair Value: RDNT is trading above our estimate of fair value.


Price to Earnings Growth Ratio

PEG Ratio: RDNT is poor value based on its PEG Ratio (3.2x)


Discover undervalued companies

Future Growth

How is RadNet forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?

Future Growth Score

2/6

Future Growth Score 2/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


17.0%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: RDNT's forecast earnings growth (17% per year) is above the savings rate (1.9%).

Earnings vs Market: RDNT's earnings (17% per year) are forecast to grow faster than the US market (13.6% per year).

High Growth Earnings: RDNT's earnings are forecast to grow, but not significantly.

Revenue vs Market: RDNT's revenue (4.9% per year) is forecast to grow slower than the US market (8.2% per year).

High Growth Revenue: RDNT's revenue (4.9% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if RDNT's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Past Performance

How has RadNet performed over the past 5 years?

Past Performance Score

4/6

Past Performance Score 4/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


13.1%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: RDNT has a large one-off loss of $30.1M impacting its March 31 2022 financial results.

Growing Profit Margin: RDNT's current net profit margins (1.4%) are higher than last year (1%).


Past Earnings Growth Analysis

Earnings Trend: RDNT's earnings have grown by 13.1% per year over the past 5 years.

Accelerating Growth: RDNT's earnings growth over the past year (66.6%) exceeds its 5-year average (13.1% per year).

Earnings vs Industry: RDNT earnings growth over the past year (66.6%) exceeded the Healthcare industry 10.1%.


Return on Equity

High ROE: RDNT's Return on Equity (9.2%) is considered low.


Discover strong past performing companies

Financial Health

How is RadNet's financial position?

Financial Health Score

2/6

Financial Health Score 2/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: RDNT's short term assets ($288.7M) do not cover its short term liabilities ($381.3M).

Long Term Liabilities: RDNT's short term assets ($288.7M) do not cover its long term liabilities ($1.3B).


Debt to Equity History and Analysis

Debt Level: RDNT's net debt to equity ratio (161.6%) is considered high.

Reducing Debt: RDNT's debt to equity ratio has reduced from 1175% to 178.4% over the past 5 years.

Debt Coverage: RDNT's debt is not well covered by operating cash flow (16.3%).

Interest Coverage: RDNT's interest payments on its debt are well covered by EBIT (5.3x coverage).


Balance Sheet


Discover healthy companies

Dividend

What is RadNet current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate RDNT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate RDNT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if RDNT's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if RDNT's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as RDNT has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

11.8yrs

Average management tenure


CEO

Howard Berger (76 yo)

35.5yrs

Tenure

US$4,567,222

Compensation

Dr. Howard G. Berger, M.D., serves as the President and Chief Financial Officer of Image Medical Corporation. Dr. Berger has been the Chief Executive Officer and President at RadNet, Inc. and its predecess...


CEO Compensation Analysis

Compensation vs Market: Howard's total compensation ($USD4.57M) is about average for companies of similar size in the US market ($USD4.04M).

Compensation vs Earnings: Howard's compensation has increased by more than 20% in the past year.


Leadership Team

Experienced Management: RDNT's management team is seasoned and experienced (11.8 years average tenure).


Board Members

Experienced Board: RDNT's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: RDNT insiders have only sold shares in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 6.7%.


Top Shareholders

Company Information

RadNet, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: RadNet, Inc.
  • Ticker: RDNT
  • Exchange: NasdaqGM
  • Founded: 1981
  • Industry: Health Care Services
  • Sector: Healthcare
  • Implied Market Cap: US$996.771m
  • Shares outstanding: 56.22m
  • Website: https://www.radnet.com

Number of Employees


Location

  • RadNet, Inc.
  • 1508, 1510 and 1516 Cotner Avenue
  • Los Angeles
  • California
  • 90025-3303
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/07/04 00:00
End of Day Share Price2022/07/01 00:00
Earnings2022/03/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.